Form 4: Arcus Biosciences COO Jennifer Jarrett Reports Stock Disposal for Tax Obligations

Sentiment:

SEC Form 4 Filing


Jennifer Jarrett, Chief Operating Officer of Arcus Biosciences, disposed of shares to cover tax obligations related to vesting RSUs.

Summary

  • On September 15, 2024, Jennifer Jarrett, the Chief Operating Officer of Arcus Biosciences, disposed of 12,670 shares of common stock.
  • The disposal was executed to cover tax withholding obligations related to the vesting and settlement of previously granted Restricted Stock Units (RSUs).
  • The shares were disposed of at a price of $17.95 per share.
  • Following the transaction, Jarrett directly owns 190,394 shares of Arcus Biosciences common stock.

Sentiment

Score: 6

Explanation: The document reflects a routine transaction (disposal of shares for tax obligations) and doesn't indicate any significant positive or negative sentiment. It's a neutral disclosure.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider transactions and are closely watched by investors.

Stakeholder Impact

  • The transaction has a minimal impact on shareholders as it is a routine disposal of shares for tax purposes and does not indicate a change in the executive's long-term outlook on the company.

Key Dates

DateDescription
09/15/2024Date of stock disposal transaction
09/17/2024Date of signature for the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.